Clozapine-induced agranulocytosis (CA) is still among the least understood adverse drug reactions in psychopharmacology. In particular, its genetic background is far from being clarified. Within the framework of a casecontrol study, we performed human leukocyte antigen (HLA) genotyping and haplotype analyses in 42 non-Jewish Caucasian schizophrenic patients (N ¼ 42) suffering from CA and 75 non-Jewish Caucasian schizophrenic patients treated with clozapine without developing CA. While controlling for age (Po0.0001) and sex (P ¼ 0.835), testing of the alleles from both HLA-loci resulted in borderline results for Cw2 (P ¼ 0.085, odds ratio (OR) ¼ 0.36, 95% confidence interval (CI): 0.08-1.23), Cw7 (P ¼ 0.058, OR ¼ 2.0, 95% CI: 0.87-4.63) and DRB5*0201 (P ¼ 0.005, adjusted OR ¼ 22.15). For haplotype analysis, we obtained significant association results with CA for the two-locus haplotypes HLA-Cw-B (P ¼ 0.022) and HLA-DRB5-DRB4 (P ¼ 0.050), and for the three-locus haplotype HLA-Cw-B-DRB5 (P ¼ 0.030). The complex nature of CA implies that many genes might play a role, but currently, only HLA associations with CA are identified as clinically relevant.
Introduction
A dysfunctional myelopoiesis resulting in agranulocytosis defined as neutrophil count of less than 0.5 Â 10 9 /l has been reported following the administration of a wide pharmacological variety of drugs. 1 Based on evidence for direct druginduced toxicity and drug-generated antineutrophil antibodies in this context, it has been hypothesized that simple toxic and immunologic pathways are in general important for developing agranulocytosis. 2 However, in some clinically relevant cases of drug-induced agranulocytosis, those clear definable pathomechanisms are not seen. 3, 4 Clozapine is thought to be the most efficacious atypical antipsychotic agent in patients with treatment-resistant schizophrenia and has proven a three fold overall reduction of risk of suicidal behaviors of schizophrenic patients. estimated rates of drug-induced agranulocytosis in general, with few cases per million population per year 7 and agranulocytosis induced by classical antipsychotics, with an incidence rate below 0.1%. 8 The pathogenesis of clozapine-induced agranulocytosis (CA) is unknown, and the discussion remains controversial whether immunological, genetic or toxic mechanisms or a multistep phenomenon are responsible for this lifethreatening side effect. 9 The delayed onset of developing agranulocytosis after initial exposure of clozapine, which lasts at least 6-12 weeks, seems to be a strong argument against simple toxic or antibody mechanisms. 10 However, the fact that CA relapse occurs with a more rapid and severe course after re-exposition to clozapine indicates at least an immunological background. 11 Support for a genetically based hypothesis is provided by findings indicating CA as an idiosyncratic drug reaction, 12 by a 21-fold higher rate of this drug adverse reaction among Finnish people compared to other ethnic backgrounds, 13 and by a case report of concordant manifestation of CA in monozygotic schizophrenic twins. 14 There are reports postulating human leukocyte antigen (HLA) class I and class II associations with adverse drug reactions, the best known are carbamazepine-induced hypersensitivity and its association with DR2 and DQ2, dipyrone-induced agranulocytosis and its association with A24, B7 and DQ1, penicilinamine-induced toxicity and the HLA association DR4, and the sulfonamide-induced toxic necrolysis with A29, B12 and DR7. However, most of these studies are based on single assessments and do need replication. 15 With respect to CA, three research groups performed HLA association studies in patients suffering from CA with adequate case numbers: The first group by Lieberman and Yunis postulated that CA was associated with HLA-B38, DRB1*0402, DQA1*0301 and DQB1 *0302 in 33 Jewish Caucasians, and with HLA DR*02, DQB1*0502 and DQA1*0102 in 19 non-Jewish Caucasian patients. 16, 17 The second group failed to replicate these findings in a sample with mainly 103 Finnish and other European patients experiencing granulocytopenia and agranulocytosis during clozapine treatment. 18 However, the studies of both groups showed major statistical and/or methodological shortcomings such as lack of clinical diagnosis or insufficient information about important clinically relevant variables with respect to drug-induced agranulocytosis such as gender and age. Our group did also fail to replicate the HLA-B38 association with CA in 31 non-Jewish Caucasian schizophrenic patients. However, we postulated that HLA Cw7 and the class II antigens DQB*0502 and DRB3*0202 might be genetic markers for this population at risk. 19, 20 To avoid statistical shortcomings with respect to HLA associations with rare idiosyncratic drug reaction, we used single-locus and haplotype-based analyses for several reasons. First, haplotype-based analyses are widely believed to provide an efficient way of exploring multivariate linkage disequilibrium patterns between markers, and to capture cis-interactions between causal variants potentially. 21 Second, in statistical terms haplotype-based methods can be viewed as an appropriate technique for reducing data dimensions, as the number of observed haplotypes is considerably smaller than the number of possible combinations of multiple loci. Third, if the risk of a disease is caused by a haplotype structure itself, and not by a single allele, haplotype-based analyses provide a better chance for detecting causative factors.
To identify patients at HLA-based risk for CA in a casecontrol design, we performed HLA genotyping and compared allele frequencies in an -compared to previous reports -enlarged sample of 42 non-Jewish Caucasian schizophrenic patients with CA and 75 non-Jewish Caucasian schizophrenic patients treated with clozapine without developing agranulocytosis. Furthermore, we calculated haplotype associations in these samples for the first time.
Results
The 42 subjects with CA had a mean age of 45. . Thus, consistent with the sampling procedure of controls and cases, we found age being associated with the risk of CA, whereas sex showed no relation to the risk developing CA. Other clinically relevant data such as duration of treatment before CA, leukocyte and neutrophil count before and after CA have been described in detail elsewhere. 22 Evaluation of global differences in allele distributions on the nine major histocompatibility complex (MHC) loci tested using the clumping approach yielded significant results for HLA-Cw (P ¼ 0.049) and for HLA-DRB5 (P ¼ 0.030).
Subsequent testing of the alleles from both loci ( To evaluate deviations from Hardy-Weinberg equilibrium, we used Pearson's w 2 -test with simulated P-value, based on 10 000 replicates. No significant deviations from Hardy-Weinberg equilibrium were found for any of the markers evaluated with P-values ranging from 0.325 (DRB3) to 1.0 (HLA-Cw, -B, -DRB1).
From the sliding-window approach, we consistently obtained significant global association results, based on asymptotic theory and on simulation, with CA, for the twolocus analyses: HLA-Cw-B (P ¼ 0.022) and HLA-DRB5-DRB4 (P ¼ 0.050), and for three three-locus analyses HLA-Cw-B-DRB5 (P ¼ 0.030). We therefore used the general linearmodeling (GLM) approach implemented in R to further Genetics of clozapine-induced agranulocytosis M Dettling et al elucidate, which specific haplotypes were associated with CA, while controlling for age and sex.
In the analysis of HLA-Cw-B haplotypes, Cw7-related alleles (Cw7-B18, P ¼ 0.035 and Cw7-B39, P ¼ 0.024) were significantly associated with CA (Table 2 ) in a dominant model, while controlling for age (Po0.0001) and sex (P ¼ 0.835). Additive models (data not shown) led to essentially the same results. The DRB5-DRB4 analysis revealed a significant association for the group of pooled alleles with a frequency below the threshold of 0.02, but not for the more common alleles. Further assessment showed that the DRB5*0201-DRB4*000 haplotype caused this association (Po0.0001; Table 2 ).
For the three-locus haplotypes, significant associations with CA were found for HLA-Cw7-B18-DRB5*000 (P ¼ 0.004), HLA-Cw7-B39-DRB5*000 (P ¼ 0.005) and HLACw7-B44-DRB5*000 (P ¼ 0.018; Table 2 ).
Discussion
To our knowledge, for the first time haplotype analyses of HLA class I and II antigens were performed in an -compared to previous reports -enlarged sample of 42 schizophrenic individuals suffering from CA. Ordered according to their physical position HLA-A-Cw, HLA-Cw-B, HLA-B-DRB5, HLA-DRB5-DRB4, HLA-DRB4-DRB3, HLA-DRB3-DRB1, HLA-BRB1-DQB and HLA-DQB-DPB were evaluated. We yielded the following results for Caucasian schizophrenic patients with CA compared to Caucasian schizophrenic controls and controlled for age and sex: (1) two Cw7-related significant two-locus haplotype associations (Cw7-B18 and Cw7-B39); (2) another two-locus haplotype, DRB5*0201-DRB4*000, was also significantly associated with CA; (3) for three-locus haplotypes, HLA-Cw7-B18-DRB5*000, HLA-Cw7-B39-DRB5*000 and HLA-Cw7-B44-DRB5*000 also displayed a significant association.
Probably, owing to the small numbers of specific HLA alleles, significant associations with CA showed large 95% CIs for ORs, including '1'. Obviously, this limitation raises concerns about generalization of our study results. However, only ORs not adjusted for covariates could be calculated, which implicates that adjusting at least for age and sex was essential when analyzing the relationship of HLA haplotypes with CA in unmatched cases and controls.
The pathomechanism of CA discussed is controversial, in particular, with respect to the degree of genetic mechanisms involved. Studies of the HLA alleles located in the short arm of chromosome 6, region 6p21, however, have always been useful in understanding immune responses and transplantation, and it is well known that HLA alleles and haplotypes are associated with several immune-and non-immunemediated diseases as well as with adverse drug reactions to xenobiotics. Thus, the HLA system seems to represent a promising target assessing an immunogenetic background of this life-threatening side effect.
In our study, HLA class I and II antigens Cw7, B38 and B39 and DRB5 seem to represent promising targets indicating mechanisms of CA not investigated so far. Interestingly, each of these targets is involved in different immunologicbased etiologies of rare and/or virus-induced diseases.
Recently, it has been shown that the proportion of natural killer (NK) cells coexpressing CD16 and CD158b þ is influenced by zygosity for the HLA-Cw7 (NK1 ligand) haplotype. As NK cells are involved in protection from virus infection, a reduced size of a ligand-specific NK subset in individuals homozygous for some HLA-B/C haplotypes might help to explain a increased susceptibility to virus-induced diseases. 23 It has also been suggested that the transplacental passage of maternal HNA-1a, HPA-3b and HLA alloantibodies specific for HLA-A3 and HLA-B38 antigens caused neutropenia and thrombocytopenia in a neonate. 24 And it is also well known that the DR15 haplotype shows the strongest genetic association with multiple sclerosis in Caucasians possibly contributing to its pathophysiology by antigen presentation. 25 As reported previously, we also found CA being significantly associated with the HLA-Cw-7 allele in a smaller subgroup of non-Jewish Caucasian schizophrenic patients with an OR of 4.2 in heterozygotes and OR of 8.4 in 
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homozygotes. Additionally, HLA class II allele coded susceptibility had been reported significantly associated with HLADQB-0502, DRB1-0101 and DRB3-0202. 19, 20 Other groups reported associations of CA with HLA-B38, DRB1-0402, DRB4-0101, DQB1-0201 and DQB1-0302 haplotypes in Jewish and HLA-DR-02, DRB1-1601, DRB5-02 and DQB1-0502 in non-Jewish Caucasian schizophrenic patients. 16, 17 Thus, some but not all of these findings are supported by our haplotype analyses in a larger sample with 42 schizophrenic patients suffering from CA.
Although our marker density is far away from mapping density currently used in fine mapping studies of linkage Means that no controls with this haplotype were available. *Means several rare alleles at one locus. P-values were accepted as significant when they were p0.05.
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M Dettling et al disequilibrium structures within the MHC, 26 it covers an important range of classic clinically relevant immunologic areas of the MHC. As our goal was to analyze genetic risk factors for CA within the MHC, we performed an association study, combining class I and class II loci, taking into account that both play different roles in immunologic responses of vertebrate organisms based on a different genetic history. 27 Interestingly, it seems that both parts of the MHC might contribute to a risk for developing CA. However, probably not as a common haplotype, spanning from MHC-I over MHC-III to MHC-II loci, but as different and independent genetic risk factors. As we had no indication for stratification, interaction effects with sex were not further analyzed; additionally, sample size limitations did not encourage further subdivisions.
Focusing on the role of HLA for CA does not mean to disregard other hypothesized immunogenetic pathways. Structures such as the Fcg receptors and its polymorphisms have also been tested for association with CA; however, data indicating Fcg receptor-related pathways playing a major role in the development of CA have not been reported. 22 We are aware that also non-immunological but genetically based hypotheses exist, but aberrations in enzymatic pathways, which result in toxic reactive metabolites and/or abnormal high concentrations of the main metabolites of clozapine or focusing on defective oxidative mechanisms of CA, have not been convincingly supported as yet. [28] [29] [30] Genetic background might play a crucial role in the induction of drug reactions such as CA. However, we are far from the purpose to appreciate the patients' genotype-based risk for this severe side effect as the complex nature of adverse drug reactions implies that many genes might play a role. Currently, only HLA associations with CA are identified as clinically relevant.
Materials and methods
Study design and sample description
The study design was described in detail elsewhere. 20 In conclusion, we performed a case-control study, where subjects with CA were traced and approached by means of the German CA surveillance system. Controls were clozapine-treated in-patients, selected from the Department of Psychiatry, Charité-University Medicine Berlin between 1996 and 2003.
The study was approved by the Ethical board of the medical faculty.
The study sample consisted of n ¼ 42 subjects with and 75 subjects without CA, who served as controls. All subjects of both groups met Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-IV) criteria for schizophrenia, paranoid type (DSM-IV, 1994) and originated from Germany.
The 42 subjects with CA received no other treatment apart from clozapine before onset of agranulocytosis, whereas comparison subjects even after a minimum 2-year period of clozapine treatment had not developed any hematotoxic reactions.
Analytic methodology
Polymerase chain reaction (PCR)-based techniques were used to identify specific alleles. DNA was isolated by standard chloroform/phenol extraction from venous leukocytes. HLA class I was genotyped by allele-specific PCR using prepipetted 96-well cyclerplates (Protrans, Ketsch, Germany). HLA class II was genotyped with an INNO-LiPA rSSO-kit (Medipro, Ketsch, Germany). PCR and hybridization conditions were applied as recommended by the manufacturers. HLA class II genotypes were addressed using InnoLipa identification software V4.0 (Innogenetics, Zwijndrecht, Belgium).
For all subjects, we obtained genotype data for HLA class I loci: HLA-A, -Cw and -B and class II loci DRB5, DRB4, DRB3, DRB1, DQB and DPB.
Statistical methods
The statistical analyses were carried out using the SPSS 12.0 (Chicago, IL, USA) and the statistical software package R 31 for Windows. A nominal significance level of 0.05 was employed.
For evaluation of global differences in single-allele distributions, we performed analyses using simulation methods as implemented in 'clump' software. 32 This approach uses Monte Carlo techniques to randomly generate new cell counts for contingency tables under the null hypothesis, while keeping the margins of the table fixed. Generally, it represents an efficient strategy to screen for interesting association in areas, where a priori knowledge is sparse. It thereby allows reducing the number of necessary statistical tests for associations by applying simulation methods developed for genetic case-control studies with sparse tables. It yields unbiased estimates of significance for HLA loci, interesting polymorphisms can then be further analyzed by conventional tests for single-allele association. For each locus, 10 000 replicates were analyzed.
We subsequently analyzed those alleles that were potentially associated to CA individually as phenotypes by Pearson's w 2 -tests, or by Fisher's exact test, when an expected cell value was less than 5 and we excluded those single alleles with an overall allele frequency below 5. Genotypespecific risks were estimated as OR using standard crossproduct ratio; CIs were calculated as mid-P intervals or Fishers exact CI accordingly.
Additionally, to avoid unrecognized associations (equivalent to type II errors) owing to the process of allele combination, we analyzed those single alleles that were found in more than 20 subjects for an association to CA. This restriction to more frequent alleles was based on two reasons: (1) risks that do not apply frequently are only of questionable practical or theoretical value in rare occurrences such as CA and (2) estimates based on very small numbers are probably more sensitive to chance.
Power calculations with realistic assumptions in our sample revealed that the probability to detect a single-allelic Genetics of clozapine-induced agranulocytosis M Dettling et al association with an OR of at least 2 was 0.84 (Genetic Power Calculator, http://statgen.iop.kcl.ac.uk/gpc/). As not all alleles at each locus were tested, tests could be regarded as essentially independent from each another.
Deviations from Hardy-Weinberg equilibrium within each group were evaluated with the R package 'Genetics', version 1.0.3. Tests were based on simulation with 10 000 iterations at each locus.
The sliding-window approach included in the R package 'haplo.stats' was used for detecting two-and three-locus (sub)-haplotype associations. Haplotypes frequencies were estimated by the expectation-maximization (EM) algorithm, associations between statistically inferred haplotypes and CA were analyzed using the score method by Schaid. 33, 34 The 'haplo.score' method assigns the probability for each haplotype pair in each individual and from there models the individual's phenotype as a function of the inferred haplotype pair. Accounting for haplotype ambiguity is carried out through weighting by their estimated probability.
Loci were ordered according to their physical position on chromosome 6p21; they were analyzed as haplotypes with phase information missing. Thus, loci evaluated as haplotypes were HLA-A-Cw, HLA-Cw-B, HLA-B-DRB5, HLA-DRB5-DRB4, HLA-DRB4-DRB3, HLA-DRB3-DRB1, HLA-BRB1-DQB and HLA-DQB-DPB. The according three-locus haplotypes were analyzed in the same way. Number of simulations for the global and specific haplotypes for empirical P-values was set to 10 000 for each two-and three-locus haplotypes.
As the haplo.score function does not provide estimates of the magnitude of genotype-phenotype associations, we further used the GLM 35 approach that incorporates haplotype phase uncertainty by inferring a probability matrix of haplotype likelihoods for each individual by use of the EM haplotype-inference algorithm rather than by assignment of a most likely haplotype phase resolution to each sample. Within this approach, haplotypes enter the design-matrix as a distinct and isolated subset among other covariates, which allows separate adjustment for different, that is, environmental or other covariates (and their interactions), while analyzing the interesting haplotype-trait association within the same model. CA was defined as a binomial trait with a logit-link function, covariates adjusted for were age and sex, which could not be matched for in our case-control design. For the regression models, the reference haplotype was the most frequent, whereas rare haplotypes were collapsed to a single category, according to the 5(2/N) criterion. Basically, the algorithm consists of a two-step iteration process: posterior probabilities of pairs of haplotypes per subject are used as weights to update regression coefficients, and regression coefficients are used to update posterior probabilities. 36 ORs were calculated with the haplo.cc function from the haplo.stats package, without adjustment for covariates.
Models with a dominant effect parameterization were performed due to rare occurrence of homozygotes in the loci evaluated. The various R packages can be obtained from http://www.R-project.org.
